[2P-678] Development of a therapeutic strategy for mouse sepsis by inhibition of the receptor for end-glycation products (RAGE) using DNA aptamers.

Yoshinori Koga¹, ^○Takanori Matsui², Ami Sotokawauchi², Yuichiro Higashimoto³, Tatsuyuki Kakuma⁴, Naoki Hashizume¹, Jun Akiba⁵, Minoru Yagi¹, Shoichi Yamagishi⁶ (1.Dept. of Pediatric Surgery., Sch. of Med., Kurume Univ., 2.Dept. of Pathophysiol. Therap. Diab. Vasc. Comp., Sch. of Med., Kurume Univ., 3.Dept. of Chem, Sch. of Med., Kurume Univ., 4.Biostatic. Ctr., Kurume Univ., 5.Dept. of Pathol., Sch. of Med., Kurume Univ., 6.Dept. of Diab. Metab. Endocrinol., Sch. of Med., Showa Univ.)